Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomesEugene Yu-hin Chan, Kjell Tullus, Tomohiko Yamamura et al.|Kidney International|2019Cited by 119